Restricting access to florbetapir: Medicare coverage criteria for diagnostics and drugs are inconsistent

被引：4

作者：

Cohen, Joshua P. ^{[1
]}

Dong, Jinghui ^{[1
]}

Lu, Christine Y. ^{[2
]}

Chakravarthy, Ranjana ^{[1
]}

机构：

[1] Tufts Univ, Boston, MA 02111 USA

[2] Harvard Univ, Sch Med, Boston, MA 02215 USA

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2015年 / 351卷

关键词：

STRUGGLE;

D O I：

10.1136/bmj.h3333

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页数：4

共 15 条

[11] Medicare's National Coverage Determinations in Diagnostic Radiology: Examining Evidence and Setting Limits [J].

Otero, Hansel Javier ;

Chambers, James D. ;

Bresnahan, Brian W. ;

Kamae, Maki S. ;

Yucel, Kent E. ;

Neumann, Peter J. .

ACADEMIC RADIOLOGY, 2012, 19 (09) :1060-1065

[12] Cost-Effectiveness of Disease-Modifying Therapies in the Management of Multiple Sclerosis for the Medicare Population [J].

Tappenden, Paul ;

McCabe, Christopher ;

Chilcott, Jim ;

Simpson, Emma ;

Nixon, Richard ;

Madan, Jason ;

Fisk, John D. ;

Brown, Murray .

VALUE IN HEALTH, 2009, 12 (05) :657-665

[13] 2013 Alzheimer's disease facts and figures Alzheimer's Association [J].

Thies, William ;

Bleiler, Laura .

ALZHEIMERS & DEMENTIA, 2013, 9 (02) :208-245

[14]

Tunis SR, 2011, IMPR QUAL EFF MED PR

[15] Alzheimer's imaging agents struggle to find a market outside trials [J].

Williams, Sarah C. P. .

NATURE MEDICINE, 2013, 19 (12) :1551-1551

← 1 2 →